Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk

por Hoogwerf, Byron J, Doshi, Krupa B, Diab, Dima
Publicado 2008

Evaluation of Diabetic Foot Ulcer Healing With Hyperspectral Imaging of Oxyhemoglobin and Deoxyhemoglobin

por Nouvong, Aksone, Hoogwerf, Byron, Mohler, Emile, Davis, Brian, Tajaddini, Azita, Medenilla, Elizabeth
Publicado 2009

Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study

por Pawaskar, Manjiri, Bonafede, Machaon, Johnson, Barbara, Fowler, Robert, Lenhart, Gregory, Hoogwerf, Byron
Publicado 2013

Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis

por Hoogwerf, Byron J., Lincoff, A. Michael, Rodriguez, Angel, Chen, Lei, Qu, Yongming
Publicado 2016

Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race

por Hoogwerf, Byron J., MacKenzie, Michele, Sealls, Whitney, Cordova, Jeanine, Gandhi, Pranav
Publicado 2020

Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes

por Ratner, Robert, Han, Jenny, Nicewarner, Dawn, Yushmanova, Irina, Hoogwerf, Byron J, Shen, Larry
Publicado 2011

Managing Type 2 Diabetes: Going Beyond Glycemic Control

por Stolar, Mark W., Hoogwerf, Byron J., Boyle, Patrick J., Gorshow, Stephen M., Wales, Dirk O.
Publicado 2008

Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study

por Tang, W.H. Wilson, McGee, Paula, Lachin, John M., Li, Daniel Y., Hoogwerf, Byron, Hazen, Stanley L.
Publicado 2018

Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study

por Gill, Anne, Hoogwerf, Byron J, Burger, Jude, Bruce, Simon, MacConell, Leigh, Yan, Ping, Braun, Daniel, Giaconia, Joseph, Malone, James
Publicado 2010

Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Loweri...

por Best, Jennie H., Hoogwerf, Byron J., Herman, William H., Pelletier, Elise M., Smith, Daniel B., Wenten, Made, Hussein, Mohamed A.
Publicado 2011

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes

por Orchard, Trevor J., Cariou, Bertrand, Connelly, Margery A., Otvos, James D., Zhang, Shuyu, Antalis, Caryl J., Ivanyi, Tibor, Hoogwerf, Byron J.
Publicado 2017

Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes

por Simeone, Jason C, Bae, Jay P, Hoogwerf, Byron J, Li, Qian, Haupt, Axel, Ali, Ayad K, Boardman, Marilyn K, Nordstrom, Beth L
Publicado 2017

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis

por Gaebler, Julia A, Soto-Campos, Gerardo, Alperin, Peter, Cohen, Marc, Blickensderfer, Amy, Wintle, Matthew, Maggs, David, Hoogwerf, Byron, Han, Jenny, Pencek, Richard, Peskin, Barbara
Publicado 2012

Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

por Pop-Busui, Rodica, Evans, Gregory W., Gerstein, Hertzel C., Fonseca, Vivian, Fleg, Jerome L., Hoogwerf, Byron J., Genuth, Saul, Grimm, Richard H., Corson, Marshall A., Prineas, Ronald
Publicado 2010

Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes

por Rosenstock, Julio, Shenouda, Sylvia K., Bergenstal, Richard M., Buse, John B., Glass, Leonard C., Heilmann, Cory R., Kwan, Anita Y.M., MacConell, Leigh A., Hoogwerf, Byron James
Publicado 2012

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

por Bonds, Denise E, Miller, Michael E, Bergenstal, Richard M, Buse, John B, Byington, Robert P, Cutler, Jeff A, Dudl, R James, Ismail-Beigi, Faramarz, Kimel, Angela R, Hoogwerf, Byron, Horowitz, Karen R, Savage, Peter J, Seaquist, Elizabeth R, Simmons, Debra L, Sivitz, William I, Speril-Hillen, Joann M, Sweeney, Mary Ellen
Publicado 2010